Highlights
NASDAQ: CYCC       Cyclacel Pharmaceuti
Last Price Today's Change   Day's Range   Trading Volume
0.623   +0.009 (1.47%)  0.58 - 0.637  180,825

Overview

 
Avg Volume (4 weeks):323,491
4 Weeks Range:0.371 - 0.794
4 Weeks Price Volatility (%):
59.57%
52 Weeks Range:0.281 - 1.18
52 Weeks Price Volatility (%):
38.04%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company which develops targeted medicines for cancer and other proliferative diseases. It develops several families of anticancer drugs that act on the cell cycle, including nucleoside analogs, CDK (cyclin dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include CYC065 CDK inhibitor, Sapacitabine and seliciclib, CYC682, CYC140 PLK inhibitor, and CYC202. The company earns the majority of its revenue from the United Kingdom.

  Be the first to like this.
 


 

2728  1521  355  4363 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 AABA 19.630.00 
 VIAB 24.22+0.75 
 AMD 42.435-0.155 
 BBT 54.24+0.75 
 CBS 40.77+1.43 
 STI 70.13+0.87 
 CHK 0.803+0.02 
 GE 11.495+0.055 
 NIO 2.40+0.13 
Partners & Brokers